Skip to main content
Fig. 9 | Molecular Neurodegeneration

Fig. 9

From: Parkinson’s disease-related Leucine-rich repeat kinase 2 modulates nuclear morphology and genomic stability in striatal projection neurons during aging

Fig. 9

Suppression of neural activity reduces nuclear invaginations in cultured Lrrk2−/− SPNs. a Co-staining of Lamin B and CTIP2 in the Lrrk2+/+ SPN cultures treated with vehicle or bicuculline. Scale bar, 10 μm. Arrow marks the site of nuclear invagination. b Percentage of the SPN nuclei containing ≥1 invagination was calculated from three independent Lrrk2+/+ cultures treated with vehicle or bicuculline. N = 200 neurons per treatment. Unpaired t-test, ***p = 0.0035. c Co-staining of Lamin B and CTIP2 in the Lrrk2−/− SPN cultures treated with vehicle or TTX. Scale bar, 10 μm. Arrow marks the site of nuclear invagination. d Percentage of SPN nuclei containing ≥1 invagination was calculated from three independent Lrrk2−/− cultures treated with vehicle, bicuculline and TTX. N = 200, 200, and 150 neurons for vehicle, bicuculline, and TTX treatment, respectively. 1way ANOVA, ****p < 0.0001. e Co-staining of Lamin B and CTIP2 in the Lrrk2RC/RC SPN cultures treated with vehicle or TTX. Scale bar, 10 μm. f Percentage of SPN nuclei containing ≥1 invagination was calculated from three independent Lrrk2RC/RC cultures treated with vehicle and TTX. N = 100 neurons per treatment, respectively. Unpaired t-test, **p = 0.0017

Back to article page